WuXi XDC Cayman Inc
2268
Peringkat dalam Saham
#1886
WuXi XDC Cayman Inc. operates as an investment holding company and a global... WuXi XDC Cayman Inc. operates as an investment holding company and a global contract research, development, and manufacturing organization (CRDMO), with operations spanning China, North America, Europe, and other international regions. The company's expertise covers the entire lifecycle, from discovery and research to development and manufacturing, of biopharmaceutical products. Specifically, it focuses on antibody-drug conjugates (ADCs), various bioconjugates, monoclonal antibody intermediates, and the crucial payload-linkers integral to bioconjugate synthesis. Founded in 2013 and headquartered in Wuxi, China, WuXi XDC Cayman Inc. is a subsidiary of WuXi Biologics (Cayman) Inc.
Harga Saham
$8.78
Kapitalisasi Pasar
$11.12B
Perubahan (1 hari)
-9.52%
Perubahan (1 tahun)
0.57%
Negara
CN
Perdagangan WuXi XDC Cayman Inc (2268)
Kategori
Healthcare
Rasio P/B untuk WuXi XDC Cayman Inc (2268)
Rasio P/B per October 2026 TTM: 6.53
Menurut laporan keuangan dan harga saham terbaru dari WuXi XDC Cayman Inc, rasio P/B saat ini (TTM) adalah 6.53. Pada akhir 2024, rasio P/B perusahaan adalah 5.20.
Riwayat rasio P/B untuk WuXi XDC Cayman Inc dari 2020 hingga 2026
Rasio P/B pada akhir setiap tahun
| Tahun | Rasio P/B | Mengubah |
|---|---|---|
| 2026 (TTM) | 6.53 | -2.87% |
| 2025 | 6.72 | 29.37% |
| 2024 | 5.20 | -10.37% |
| 2023 | 5.80 | -70.54% |
| 2022 | 19.68 | -98.47% |
| 2021 | 1.29K | 1,641.63% |
| 2020 | 73.89 | 0.00% |
Rasio P/B untuk perusahaan sejenis atau pesaing
| Perusahaan | Rasio P/B | Perbedaan Rasio P/B | Negara |
|---|---|---|---|
| 4.7411 | -27.36% |
US
|
|
| 3.0143 | -53.82% |
US
|
|
| 31.051 | 375.74% |
US
|
|
| 4.9326 | -24.43% |
CN
|
|
| 6.8081 | 4.31% |
US
|
